CELLERITAS

Welcome to the Brand page for “CELLERITAS”, which is offered here for Manufacturing services for others in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals, plasmid dna production; manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (aav), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; manufacturing process consulting;research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; research and development of new products for others; process development services in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; scientific research and technical research services, production of cell lines for others using lentivirus technology; scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (aav), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, cgmp (current good manufacturing practice) quality control testing in support of biopharmaceutical development and manufacturing; quality control for others; quality management services, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; material testing; product quality testing; scientific laboratory services; scientific research; research and development in the field of gene therapy acceleration, vector genome copy titers, droplet digital polymerase chain reaction (pcr) and digital polymerase chain reaction (pcr), mass spectrometry, capsid characterization, bioassays, plasmid dna, and analytics testing in the field of genes and gene therapy;.

Its status is currently believed to be active. Its class is unavailable. “CELLERITAS” is believed to be currently owned by “CENTER FOR BREAKTHROUGH MEDICINES HOLDINGS, LLC”.